The global downstream processing market was valued at USD 21.36 billion in 2020 and is expected to grow at a CAGR of 15.5% during the forecast period. A significant factor driving market demand is the increased use of downstream processing techniques for the production of COVID-19 vaccines.
了解有关此报告的更多信息:request for sample pages
For instance, in February 2021, Rentschler Biopharma will begin CureVac commercial production, formulation, and downstream processing of candidate vaccine. Bayer has also announced that 160 million doses of CVnCoV will be produced, in 2022.
Growth Drivers
In January 2021, Thermo Fisher announced it will support 250 projects for COVID-19 treatment and vaccine progress in the coming years. These ventures make use of the company's CDMO proficiencies and its bioprocess consumable materials and equipment. It also formed alliances with Singapore and the U.S. government to increase vaccine and therapy production.
关于创新生物过程技术的研究和发展活动的增加导致了高分辨率膜系统,高通量过程开发,多组分分离和灌注色谱系统的恒定下游加工系统的实施。
下游制造业的CMOS数量因外包制药商的高初始资本支出和流程成本而发展。除混合,一次性技术,细胞培养制备,浓缩,色谱和过程控制外,CMOS还有助于制药公司提高下游净化。
该市场主要基于产品,技术,应用和区域进行分段。
由产品 |
By Technique |
通过申请 |
按地区 |
|
|
|
|
了解有关此报告的更多信息:request for sample pages
Chromatography systems accounted for the largest revenue share of the downstream processing market. Due to continuous R&D to improve the efficacy and pace of chromatography systems, the segment is expected to develop. Growth in the chromatography systems segment is also helped by an increase in deals and innovations.
例如,Sartorius Stedim Biotech于1月2021年宣布,它将获得Novasep的色谱设备公司。Sartorius将能够以此创建新的色谱系统,这将有助于公司解决下游处理中的可靠性问题和瓶颈。
色谱法纯化占全球下游加工行业的最大市场份额于2020年。公司正在遵循市场扩张策略,如合并,收购和协议,以将其色谱法作为过滤系统和单用色谱众所周知,众所周知在下游生物加工。
For instance, Repligen Corporation has entered into an acquisition agreement with ARTeSYN Biosolutions in, October 2020. ARTeSYN Biosolutions is a well-known manufacturer of single-use filtration and chromatography equipment. The company also offers a variety of single-use solutions for continuous production and media/buffer planning workflows.
由于抗生素的广泛使用治疗几种疾病,抗生素发育占据了下游制造业,2020年,收入份额最大。抗生素的细菌每年杀死超过70万人。因此,存在强大的市场对抗生素的生产需求,这提出了下游加工的市场增长。
Due to the rising government funding for promoting bioprocess technology, increasing medical spending, and developed healthcare infrastructure, North America dominated the downstream processing market with the largest revenue share, in 2020. Besides, the area has seen significant collaboration with healthcare behemoths that are heavily investing in biopharmaceutical and vaccine R&D.
此外,下游加工行业的主要球员正在扩大他们在该地区的存在。例如,Thermo Fisher Scientific Inc.于2020年12月宣布,它将扩大其在欧洲和北美的药物,疫苗和疗法的商业制造。
The development incorporated 15 development and cGMP commercial manufacturing facilities, allowing the company to serve a wide variety of manufacturing capabilities while maintaining its high-quality standards.
Owing to the growing biotechnology investments by developers and customers, the market demand for downstream processing in the Asia Pacific is projected to expand at the fastest pace of 17.5%. The need for advanced medical facilities is being driven by the existence of a broad population base, and players are eager to introduce rapid analytical methods to help in-process design and bioprocessing.
由于生物制药业升高和市场对药品和疫苗的需求,中国在亚太下游加工市场中占据了市场份额。生物制药业是中国最活跃的经济产业之一,新的生物制药设备和流程不断彻底彻底改变行业。yabo88更新
下游处理市场中的主要参与者正在集中精力对战略收购的能量来提高他们的研发能力,这将有助于他们为用户提供创造性解决方案并获得竞争优势。
Market participants such as 3M Company, Danaher Corporation, Ashai Kasei, Corning Corporation, Lonza Group Ltd, Boehringer Ingelheim International GmbH, Dover Corporation, Eppendorf AG, Ferner PLC, Merck KGaA, GE Healthcare, Sartorius Stedim Biotech S.A, Thermo Fisher Scientific Inc., and Repligen are some of the companies operating in the market for downstream processing.